New hope for tough ovarian cancers: targeted drug CUSP06 enters human testing
Disease control
Recruiting now
This study tests a new drug called CUSP06 for people with ovarian cancer or other solid tumors that have stopped responding to standard treatments. The drug works like a guided missile, targeting a protein on cancer cells to deliver a powerful toxin directly. The main goals are t…
Phase: PHASE1 • Sponsor: OnCusp Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC